CORRECTION article
Front. Pharmacol.
Sec. Pharmacology of Anti-Cancer Drugs
Volume 16 - 2025 | doi: 10.3389/fphar.2025.1662270
Current paradigm and futuristic vision on new-onset diabetes and pancreatic cancer research
Provisionally accepted- 1The University of Texas Rio Grande Valley, Edinburg, United States
- 2National Institute of Technology Srinagar, Srinagar, India
- 3The University of Memphis, Memphis, United States
- 4Baptist Health Sciences University, Memphis, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
A correction refers to a change to their article that the author wishes to publish after publication. The publication of this article is subject to Frontiers' editorial approval. • Please read through all the templates before choosing • Pick the most relevant text template(s) from the following page and delete all others.• Edit the text as necessary, ensuring that the original incorrect text is included for the record, please see the below. • Please do not use any extra formatting when editing the templates, and only modify the red text unless absolutely necessary • Submit to Frontiers following the instructions on this page.When the original text contained incorrect information, to preserve the scientific record, please include that text when editing the below templates. For example:There was a mistake in the Funding statement, an incorrect number was used. The correct number is '2015C03Bd051'. The publisher apologizes for this mistake.The original version of this article has been updated. In the published article, the link to the supplementary results in the published article appears to be incomplete or misdirected, as it does not display Supplementary Figure S1 [Interactome analysis of curated gene set by using GeneMania]. This figure was included and reviewed during the peer review process and was approved as part of the supplementary material. It appears the omission occurred during journal production. We kindly ask that this be corrected to ensure the complete set of supplementary data is available to readers. The missing material appears below. Adding this does not change the scientific conclusions of the article in any way.
Keywords: Pancreatic Cancer, New-onset diabetes, biomarker, socioecnomic factor, Screening -
Received: 08 Jul 2025; Accepted: 10 Jul 2025.
Copyright: © 2025 Moreland, Arredondo, Dhasmana, Dhasmana, Shabir, Siddiqua, Banerjee, Yallapu, Behrman, Chauhan and Khan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Sheema Khan, The University of Texas Rio Grande Valley, Edinburg, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.